Emergency winrevair
Ended Awarded Last action
- Contract number
- 36C26225F0329
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 22
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $336,623
Award facts
- Contract value 100% obligated
- $336,622.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$10,545 | |
| Supplemental Agreement for work within scope | $105,210 | |
| Original award | $241,958 |
About this award
Merck Sharp & Dohme LLC (Merck) was awarded a delivery order valued at $336,622.94 on March 10, 2025, for emergency procurement of WINREVAIR (sotatercept-csrk), a pharmaceutical treatment for pulmonary hypertension. The delivery order is issued under Merck's parent Federal Supply Schedule contract (FSS-61-IB) for Pharmaceuticals and Drugs with the Department of Veterans Affairs, valued at $5.84 billion and extending through May 31, 2030. This non-competitive delivery order carries no set-aside designation and is structured as a firm fixed-price contract with an ultimate completion date of December 31, 2025. Performance will take place in Bartlett, Tennessee, serving the Veterans Integrated Service Network 22, which oversees healthcare delivery to veterans across a multi-state region.
This delivery order reflects the Department of Veterans Affairs' utilization of its established GSA schedule vehicle to procure critical pharmaceutical products for veteran beneficiaries on an emergency basis. Merck's extensive federal contracting history, including significant portfolios with the Department of Defense, Centers for Disease Control and Prevention, and Department of Health and Human Services, positions the company as a primary supplier of specialty therapeutics and vaccines to federal healthcare programs. The emergency designation underscores the urgent medical need for this pulmonary hypertension treatment within the VA healthcare system.
Quick answers
Who was awarded contract 36C26225F0329?
36C26225F0329 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 22 (Veterans Health Administration) on March 10, 2025.
How much is contract 36C26225F0329 worth?
The government has obligated $336,623 on 36C26225F0329.
Is contract 36C26225F0329 an order under another contract?
Yes. 36C26225F0329 is a delivery order under 36F79718D0509, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26225F0329 competed?
The extent of competition for 36C26225F0329 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award